India ALL Vaccine Market Research Report 2017

  • Apr 2017
  • By QY Research
  • 126 pages
  • Report Id: 90164

India ALL Vaccine Market Research Report 2017

  • Apr 2017
  • By QY Research
  • 126 pages
  • Report Id: 90164
The global ALL Vaccine market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

India plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the ALL Vaccine development status and future trend in India, focuses on top players in India, also splits ALL Vaccine by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in India market include Pfizer, Inc., Glaxosmithkline, PLC., Merck & Co., Inc., Novarits, Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC. (A Subsidiary of Astrazeneca), Astellas Pharma Inc., Mitsubishi Tanabe, Dynavax Technologies, Novavax


Geographically, this report splits the India market into six regions,
North India
South India
East India
West India
Northeast India
Central India

On the basis of product, the ALL Vaccine market is primarily split into
Vaccinia
Measles, mumps, rubella
Varicella
Influenza
Rotavirus
Zoster
Yellow Fever
Polio
Hepatitis A
Rabies
BCG
Diphtheria, tetanus
Hepatitis B
Haemophilus influenzae type b
Pertussis
Human papillomavirus
Meningococcal
Pneumococcal



On the basis on the end users/applications, this report covers
For Adult
For Child


Table of Contents

India ALL Vaccine Market Research Report 2017
1 ALL Vaccine Overview
1.1 Product Overview and Scope of ALL Vaccine
1.2 Classification of ALL Vaccine by Product Category
1.2.1 India ALL Vaccine Sales (K Units) Comparison by Types (2012-2022)
1.2.2 India ALL Vaccine Sales (K Units) Market Share by Types (Product Category) in 2016
1.2.3 Vaccinia
1.2.4 Measles, mumps, rubella
1.2.5 Varicella
1.2.6 Influenza
1.2.7 Rotavirus
1.2.8 Zoster
1.2.9 Yellow Fever
1.2.10 Polio
1.2.11 Hepatitis A
1.2.12 Rabies
1.2.13 BCG
1.2.14 Diphtheria, tetanus
1.2.15 Hepatitis B
1.2.16 Haemophilus influenzae type b
1.2.17 Pertussis
1.2.18 Human papillomavirus
1.2.19 Meningococcal
1.2.20 Pneumococcal
1.3 India ALL Vaccine Market by Applications/End Users
1.3.1 India ALL Vaccine Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 For Adult
1.3.3 For Child
1.4 India ALL Vaccine Market by Regions
1.4.1 India ALL Vaccine Market Size (Million USD) Comparison by Regions (2012-2022)
1.4.2 North India ALL Vaccine Status and Prospect (2012-2022)
1.4.3 South India ALL Vaccine Status and Prospect (2012-2022)
1.4.4 East India ALL Vaccine Status and Prospect (2012-2022)
1.4.5 West India ALL Vaccine Status and Prospect (2012-2022)
1.4.6 Northeast India of US ALL Vaccine Status and Prospect (2012-2022)
1.4.7 Central India ALL Vaccine Status and Prospect (2012-2022)
1.5 India Market Size (Sales and Revenue) of ALL Vaccine (2012-2022)
1.5.1 India ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
1.5.2 India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
2 India ALL Vaccine Market Competition by Players/Manufacturers
2.1 India ALL Vaccine Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 India ALL Vaccine Revenue and Share by Players/Manufacturers (2012-2017)
2.3 India ALL Vaccine Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 India ALL Vaccine Market Competitive Situation and Trends
2.4.1 India ALL Vaccine Market Concentration Rate
2.4.2 India ALL Vaccine Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in India Market
2.5 India Players/Manufacturers ALL Vaccine Manufacturing Base Distribution, Sales Area, Product Types
3 India ALL Vaccine Sales and Revenue by Regions (2012-2017)
3.1 India ALL Vaccine Sales (K Units) and Market Share by Regions (2012-2017)
3.2 India ALL Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
3.3 India ALL Vaccine Price (USD/Unit) by Regions (2012-2017)
4 India ALL Vaccine Sales and Revenue by Type/ Product Category (2012-2017)
4.1 India ALL Vaccine Sales (K Units) and Market Share by Type/ Product Category (2012-2017)
4.2 India ALL Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 India ALL Vaccine Price (USD/Unit) by Type (2012-2017)
4.4 India ALL Vaccine Sales Growth Rate (%) (%) by Type (2012-2017)
5 India ALL Vaccine Sales by Application (2012-2017)
5.1 India ALL Vaccine Sales (K Units) and Market Share by Applications (2012-2017)
5.2 India ALL Vaccine Sales Growth Rate (%) (%) by Applications (2012-2017)
5.3 Market Drivers and Opportunities
6 India ALL Vaccine Players/Manufacturers Profiles and Sales Data
6.1 Pfizer, Inc.
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 ALL Vaccine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Glaxosmithkline, PLC.
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 ALL Vaccine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 ALL Vaccine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novarits
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 ALL Vaccine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi Pasteur
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 ALL Vaccine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 CSL Limited
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 ALL Vaccine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Emergent Biosolutions, Inc.
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 ALL Vaccine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Johnson & Johnson
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 ALL Vaccine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 ALL Vaccine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Astellas Pharma Inc.
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 ALL Vaccine Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Mitsubishi Tanabe
6.12 Dynavax Technologies
6.13 Novavax
7 ALL Vaccine Manufacturing Cost Analysis
7.1 ALL Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of ALL Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 ALL Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 India ALL Vaccine Market Size (Sales and Revenue) Forecast (2017-2022)
11.1 India ALL Vaccine Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
11.2 India ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
11.3 India ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
11.4 India ALL Vaccine Sales (K Units) Forecast by Regions (2017-2022)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Tables and Figures

Figure Global and India Market Size (Million USD) Comparison2012-2022
Table ALL Vaccine Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table ALL Vaccine Sales (K Units) by Application (2016-2022)
Figure Product Picture of ALL Vaccine
Table India ALL Vaccine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2022)
Figure India ALL Vaccine Sales Volume Market Share by Types (Product Category) in 2016
Figure Vaccinia Product Picture
Figure Measles, mumps, rubella Product Picture
Figure Varicella Product Picture
Figure Influenza Product Picture
Figure Rotavirus Product Picture
Table India ALL Vaccine Sales (K Units) Comparison by Applications (2012-2022)
Figure India Sales Market Share (%) of ALL Vaccine by Applications in 2016
Figure For Adult Examples
Figure For Child Examples
Figure North India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure South India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure East India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure West India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Northeast India of US ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Central India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Figure India ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Table India ALL Vaccine Sales of Key Players/Manufacturers (2012-2017)
Table India ALL Vaccine Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 India ALL Vaccine Sales Share (%) by Players/Manufacturers
Figure 2017 India ALL Vaccine Sales Share (%) by Players/Manufacturers
Table India ALL Vaccine Revenue by Players/Manufacturers (2012-2017)
Table India ALL Vaccine Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 India ALL Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2017 India ALL Vaccine Revenue Market Share (%) by Players/Manufacturers
Table India Market ALL Vaccine Average Price of Key Players/Manufacturers (2012-2017)
Figure India Market ALL Vaccine Average Price of Key Players/Manufacturers in 2016
Figure India ALL Vaccine Market Share of Top 3 Players/Manufacturers
Figure India ALL Vaccine Market Share of Top 5 Players/Manufacturers
Table India Players/Manufacturers ALL Vaccine Manufacturing Base Distribution and Sales Area
Table India Players/Manufacturers ALL Vaccine Product Category
Table India ALL Vaccine Sales (K Units) by Regions (2012-2017)
Table India ALL Vaccine Sales Share (%) by Regions (2012-2017)
Figure India ALL Vaccine Sales Share (%) by Regions (2012-2017)
Figure India ALL Vaccine Sales Market Share (%) by Regions in 2016
Table India ALL Vaccine Revenue (Million USD) and Market Share by Regions (2012-2017)
Table India ALL Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure India ALL Vaccine Revenue Market Share (%) by Regions (2012-2017)
Figure India ALL Vaccine Revenue Market Share (%) by Regions in 2016
Table India ALL Vaccine Price (USD/Unit) by Regions (2012-2017)
Table India ALL Vaccine Sales (K Units) by Type (2012-2017)
Table India ALL Vaccine Sales Share (%) by Type (2012-2017)
Figure India ALL Vaccine Sales Share (%) by Type (2012-2017)
Figure India ALL Vaccine Sales Market Share (%) by Type in 2016
Table India ALL Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table India ALL Vaccine Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of ALL Vaccine by Type (2012-2017)
Figure Revenue Market Share of ALL Vaccine by Type in 2016
Table India ALL Vaccine Price (USD/Unit) by Types (2012-2017)
Figure India ALL Vaccine Sales Growth Rate (%) (%) by Type (2012-2017)
Table India ALL Vaccine Sales (K Units) by Applications (2012-2017)
Table India ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure India ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure India ALL Vaccine Sales Market Share (%) by Applications in 2016
Table India ALL Vaccine Sales Growth Rate (%) (%) by Applications (2012-2017)
Figure India ALL Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Glaxosmithkline, PLC. Basic Information List
Table Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Novarits Basic Information List
Table Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Novarits ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure CSL Limited ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Emergent Biosolutions, Inc. Basic Information List
Table Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Johnson & Johnson ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) Basic Information List
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Market Share (%) in US (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Revenue Market Share (%) in US (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ALL Vaccine
Figure Manufacturing Process Analysis of ALL Vaccine
Figure ALL Vaccine Industrial Chain Analysis
Table Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
Table Major Buyers of ALL Vaccine
Table Distributors/Traders List
Figure India ALL Vaccine Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure India ALL Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India ALL Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table India ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure India ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure India ALL Vaccine Sales Volume Market Share Forecast by Type in 2022
Table India ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
Figure India ALL Vaccine Sales Volume Market Share Forecast by Application (2017-2022)
Figure India ALL Vaccine Sales Volume Market Share Forecast by Application in 2022
Table India ALL Vaccine Sales (K Units) Forecast by Regions (2017-2022)
Table India ALL Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure India ALL Vaccine Sales Volume Share Forecast by Regions (2017-2022)
Figure India ALL Vaccine Sales Volume Share Forecast by Regions in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources